Exelixis reported $2.45B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 717.67M 6.76M
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Agios Pharmaceuticals AGIO:US $ 1541.5M 333.1M
Akebia Therapeutics AKBA:US $ 602.27M 9.6M
Amgen AMGN:US $ 64993M 5220M
AstraZeneca AZN:LN 107221M 33580M
Bayer BAYN:GR € 116549M 2122M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Bristol Myers Squibb BMY:US $ 110893M 96M
Cytokinetics CYTK:US $ 827.54M 263.24M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Eisai 4523:JP Y 1140111M 10770M
Eli Lilly And LLY:US $ 48187M 378M
Esperion Therapeutics ESPR:US $ 225.26M 55.2M
Exelixis EXEL:US $ 2447.74M 80.47M
Genmab GEN:DC DK 23985M 1502M
Glaxosmithkline GSK:US $ 78689M 1678M
Immunogen IMGN:US $ 296.8M 4.64M
IONIS PHARMACEUT IONS:US $ 2415M 82.07M
Macrogenics MGNX:US $ 392.16M 33.75M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Moderna Inc MRNA:US 20.92B 4.77B
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Neurocrine Biosciences NBIX:US $ 2017.3M 60.9M
Novartis NOVN:VX SF 121209M 2806M
Puma Biotechnology PBYI:US $ 226.29M 33.71M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Takeda 4502:JP Y 12560273M 96961M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M
Xencor XNCR:US $ 697.26M 1.66M
YTE INCY:US $ 4198.83M 294.21M